Anika Therapeutics Inc

NASDAQ:ANIKUnited States

Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.

Contact Information

Headquarters

32 Wiggins AveBEDFORD, MA, United States 01730-2315

Phone

781-457-9000

Fax

781-305-9720

Executives

Independent Chairman of the Board

John Henneman

Interim Chief Executive Officer, Director

Cheryl Blanchard

Executive Vice President, Chief Financial Officer, Treasurer

Stephen Griffin

Chief Operations Officer, Senior Vice President

Anne Nunes

Executive Vice President, General Counsel, Secretary

David Colleran